According to Zoetis's latest financial reports the company's current revenue (TTM) is $8.54 B. In 2022 the company made a revenue of $8.08 B an increase over the years 2021 revenue that were of $7.77 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $8.54 B | 5.74% |
2022 | $8.08 B | 3.91% |
2021 | $7.77 B | 16.49% |
2020 | $6.67 B | 6.63% |
2019 | $6.26 B | 7.47% |
2018 | $5.82 B | 9.76% |
2017 | $5.30 B | 8.57% |
2016 | $4.88 B | 2.58% |
2015 | $4.76 B | -0.42% |
2014 | $4.78 B | 4.91% |
2013 | $4.56 B | 5.19% |
2012 | $4.33 B | 2.43% |
2011 | $4.23 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 584.66% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 299.39% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 489.42% | ๐ซ๐ท France |
Merck MRK | $60.11 B | 603.58% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.98 B | -88.51% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | $7.92 M | -99.91% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.25 B | -97.02% | ๐บ๐ธ USA |